Singapore markets closed

scPharmaceuticals Inc. (2SX.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
3.6000-0.1000 (-2.70%)
As of 08:45AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-57,708
-54,810
-36,838
-28,034
-32,209
-
Depreciation & amortisation
572
626
468
438
399
-
Stock-based compensation
5,316
4,856
2,838
2,366
2,000
-
Change in working capital
-3,464
-6,321
-350
-2,599
1,448
-
Accounts receivable
-2,768
-4,489
0
-
-
-
Inventory
-5,977
-7,609
-1,230
0
-
-
Accounts payable
4,377
5,556
1,767
-2,365
1,212
-
Other working capital
-60,491
-59,284
-34,598
-27,160
-27,693
-
Other non-cash items
2,289
2,166
884
554
639
-
Net cash provided by operating activities
-60,451
-59,244
-34,577
-27,151
-27,693
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-40
-21
-9
-
-
Purchases of investments
-
-50,595
-67,538
-9,011
-72,160
-
Sales/maturities of investments
92,919
70,600
21,700
41,150
38,700
-
Net cash used for investing activities
42,284
19,965
-45,859
32,130
-33,460
-
Cash flows from financing activities
Debt repayment
-
0
-17,500
-2,500
0
-
Common stock issued
334
14,038
47,765
0
60,576
-
Common stock repurchased
-
-
-
-81
-164
0
Other financing activities
-
-
-554
-81
-800
-
Net cash used provided by (used for) financing activities
1,161
14,850
77,229
-2,530
60,348
-
Net change in cash
-17,006
-24,429
-3,207
2,449
-805
-
Cash at beginning of period
75,453
71,243
74,450
72,001
72,806
-
Cash at end of period
58,447
46,814
71,243
74,450
72,001
-
Free cash flow
Operating cash flow
-60,451
-59,244
-34,577
-27,151
-27,693
-
Capital expenditure
-
-40
-21
-9
-
-
Free cash flow
-60,491
-59,284
-34,598
-27,160
-27,693
-